Most CBD-rich products in the market today include 1-20% CBD, while Kanabo’s OTC formulas include a broad spectrum of Cannabis extract of up to 78% of CBD + Cannabinoids due to patent pending compositions.
The formulas are made with a proprietary, patent-pending carrier solution that replaces the traditional electronic cigarette liquids like PG/VG and MCT extract diluents that dominate the market, and are suspected to release toxic materials when heated to the higher temperatures required for cannabis extract (unlike e-liquid based products).
Kanabo’s proprietary neutral diluent allows for little to no irritation, high potency, and consistent dosing through the lifespan of the formula pod with superior bioavailability, as indicated by Kanabo’s clinical medical trials.
